Use of a clinical decision support tool to improve guideline adherence for the treatment of methicillin-resistant staphylococcus aureus: Skin and soft tissue infections

Advanced Emergency Nursing Journal

Volumn 33, Issue 3, 2011, Pages 252-266

  Carman, Margaret Jean ^a   Phipps, Julie ^b   Raley, Jennifer ^c   Li, Suling ^d   Thornlow, Deirdre ^a  

^a DUKE UNIVERSITY   (United States)

^b WAKEMED HEALTH AND HOSPITALS   (United States)

^c Wake Emergency Physician PA   (United States)

^d Emergency Nurses Association   (United States)

Author keywords

abscess; clinical decision support; methicillin resistant Staphylococcus aureus; MRSA

Indexed keywords

ADULT; ARTICLE; DECISION SUPPORT SYSTEM; ELECTRONIC MEDICAL RECORD; EMERGENCY HEALTH SERVICE; EVIDENCE BASED PRACTICE; FEMALE; HEALTH CARE SURVEY; HUMAN; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NURSING; PRACTICE GUIDELINE; SOFT TISSUE INFECTION; STANDARD; STAPHYLOCOCCAL SKIN INFECTION;

ADULT; DECISION SUPPORT SYSTEMS, CLINICAL; ELECTRONIC HEALTH RECORDS; EMERGENCY MEDICAL SERVICES; EVIDENCE-BASED PRACTICE; FEMALE; GUIDELINE ADHERENCE; HEALTH CARE SURVEYS; HUMANS; MALE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; SOFT TISSUE INFECTIONS; STAPHYLOCOCCAL SKIN INFECTIONS;

EID: 80052243234     PISSN: 19314485     EISSN: None     Source Type: Journal    
DOI: 10.1097/TME.0b013e31822610d1     Document Type: Article

References (17)

1. SPICE, N.C. (2007). North Carolina Consensus Guideline for Management of Suspected Community-Acquired Staphylococcus aureus (CA-MRSA). Skin and Soft Tissue Infections (SSTI's). Retrieved September 6, 2010, from North Carolina Division of Public Health: http://www.unc.edu/depts/spice/CA-MRSA-2007-03-05.pdf
2. Christakis, D. (2001). A randomized controlled trial of point-of-care evidence to improve the antibiotic prescribing practices for otitis media in children. Retrieved September 20, 2009, from http://www.pediatrics.org/cgi/ content/full/107/2/e15
3. Cohen, P. (2007). Community-acquired methicillin-resistant Staphylococcus aureus skin infections. American Journal of Clinical Dermatology, 8 (5), 259-270.
4. Daum, R. (2007). Skin and soft tissue infections caused by methicillin-resistant Staphylococcus aureus. New England Journal of Medicine, 357, 380-390.
5. Dellit, T. D. (2007). Guidelines for evaluation and management of community-associated methicillin-resistant Staphylococcus aureus skin and soft tissue infections in outpatient settings. Seattle and King County, WA: Infectious Diseases Society of Washington.
6. Ellis, M. G., Griffith, M. E., Dooley, D. P., McLean, J. C., Jorgensen, J. H., Patterson, J. E., & Hos-penthal, D. R. (2007). Targeted Intranasal Mupirocin to Prevent Colonization and Infection by Community-Associated Methicilllin-Resistant Staphylococcus au-reus Strains in Soldiers: A Cluster Randomized Controlled Trial. Antimicrobial Agents and Chemotherapy, 51, 3591-3598. (Pubitemid 47519348)
7. Fisher, R., Chain, R. L., Hair, P. S., & Cunnion, K. M. (2008). Hypochlorite killing of community-acquired methicillin-resistant Staphylococcus aureus. Pedi-atric Infectious Disease Journal, 27, 934-935.
8. Garg, A., Adhikari, N. K., McDonald, H., Rosas-Arellano, M. P., Devereaux, P. J., Beyene, J., & Haynes, R. B. (2005). Effects of computerized clinical decision support systems on practitioner performance and patient outcomes: A systematic review. JAMA, 293, 1223-1238. (Pubitemid 40327908)
9. Gorwitz, R. J. (2006). Strategies for clinical management of MRSA in the community: Summary of an experts' meeting convened by the Centers for Diease Control and Prevention. Washington, DC: Centers for Disease Control and Prevention.
10. Kowalski, T. B., Berbari, E. F., & Osmon, D. R. (2005). Epidemiology, treatment, and prevention of community-acquired methicillin-resistant Staphylococcus aureus infections. Mayo Clinic Proceedings,80, 1201-1208. (Pubitemid 41233357)
11. McConeghey, K., Mikolich, D. J., & LaPlante, K. L. (2009). Agents for the decolonization of methicillin-resistant Staphylococcus aures. Pharmacotherapy, 29, 263-280.
12. McGregor, J. D. C., Dumyati, G., Casiano-Colón, A. E., Chang, P. J., & Klevens, R. M. (2009). Usefulness of antibiogram surveillance for methicillin-resistant Staphylococcus aureus in outpatient pediatric populations. Diagnostic Microbiology and Infectious Disease, 64, 70-75.
13. Miller, L. P. R., Perdreau-Remington, F., Bayer, A. S., Diep, B., Tan, N., Bharadwa, K., & Spellberg, L. (2007). Clinical and epidemiological characteristics cannot distinguish community-aquired methicillin-resistant nStaphylococcus infection from methicillin-susceptible S. aureus infection: a prospective investigation. Clinical Infectious Diseases, 44, 471-482. (Pubitemid 46233247)
14. Moran, G. K., Krishnadasan, A., Gorwitz, R. J., Fosheim, G. E., McDougal, L. K., & Carey, R. B. Emergency ID Net Study Group (2006). Methicillin-resistant S. au-reus infections among patients in the emergency department. New England Journal of Medicine, 355, 666-674.
15. Sattler, C. M., Mason, E. O. Jr, & Kaplan, S. L. (2002). Prospective comparison of risk factors and demographic and clinical characteristics of community-acquired methicillin-resistant versus methicillin-susceptible Staphylococcus infection in children. Pediatric Infectious Disease Journal, 21, 910-917.
16. Shapiro, A. R., Raman, S., Johnson, M., & Piehl, M. (2009). Community-acquired MRSA infections in North Carolina children: Prevalence, antibiotic sensitivities, and risk factors. North Carolina Medical Journal, 70, 102-107.
17. Wells, R.M., Mason, P., Roarty, J., & Dooley, M. (2009). Comparison of initial antibiotic choice and treatment of cellulitis in the pre-and post-community-acquired methicillin-resistant Staphylococcus aureus eras. American Journal of Emergency Medicine, 27, 436-439.